201 related articles for article (PubMed ID: 20425257)
1. New technologies personalize diagnostics and therapeutics.
Rosenson RS
Curr Atheroscler Rep; 2010 May; 12(3):184-6. PubMed ID: 20425257
[TBL] [Abstract][Full Text] [Related]
2. Role of Proteomics in the Development of Personalized Medicine.
Jain KK
Adv Protein Chem Struct Biol; 2016; 102():41-52. PubMed ID: 26827601
[TBL] [Abstract][Full Text] [Related]
3. Post-genomics nanotechnology is gaining momentum: nanoproteomics and applications in life sciences.
Kobeissy FH; Gulbakan B; Alawieh A; Karam P; Zhang Z; Guingab-Cagmat JD; Mondello S; Tan W; Anagli J; Wang K
OMICS; 2014 Feb; 18(2):111-31. PubMed ID: 24410486
[TBL] [Abstract][Full Text] [Related]
4. Novel molecular biomarkers and diagnosis of acute appendicitis in children.
Hodge SV; Mickiewicz B; Lau M; Jenne CN; Thompson GC
Biomark Med; 2021 Aug; 15(12):1055-1065. PubMed ID: 34284638
[TBL] [Abstract][Full Text] [Related]
5. Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.
Joshi MS; Montgomery KA; Giannone PJ; Bauer JA; Hanna MH
Pediatr Res; 2017 Jan; 81(1-2):271-276. PubMed ID: 27723726
[TBL] [Abstract][Full Text] [Related]
6. Personalized Management of Cardiovascular Disorders.
Jain KK
Med Princ Pract; 2017; 26(5):399-414. PubMed ID: 28898880
[TBL] [Abstract][Full Text] [Related]
7. Untargeted Metabolomics in the Discovery of Novel Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Diseases.
Dang VT; Huang A; Werstuck GH
Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):166-175. PubMed ID: 29683098
[TBL] [Abstract][Full Text] [Related]
8. Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision Medicine.
Patel KV; Pandey A; de Lemos JA
Circulation; 2018 Jun; 137(24):2551-2553. PubMed ID: 29643058
[No Abstract] [Full Text] [Related]
9. Precision Medicine and Personalized Medicine in Cardiovascular Disease.
Currie G; Delles C
Adv Exp Med Biol; 2018; 1065():589-605. PubMed ID: 30051409
[TBL] [Abstract][Full Text] [Related]
10. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
Tebani A; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
[TBL] [Abstract][Full Text] [Related]
11. Nanochannel systems for personalized therapy and laboratory diagnostics.
Grattoni A; Fine D; Ziemys A; Gill J; Zabre E; Goodall R; Ferrari M
Curr Pharm Biotechnol; 2010 Jun; 11(4):343-65. PubMed ID: 20199382
[TBL] [Abstract][Full Text] [Related]
12. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
13. Theranostics: rethinking postgenomic diagnostics.
Özdemir V; Cho WC
Expert Rev Mol Diagn; 2012 Nov; 12(8):783-5. PubMed ID: 23249192
[No Abstract] [Full Text] [Related]
14. Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention.
Aleksandrova K; Egea Rodrigues C; Floegel A; Ahrens W
Curr Obes Rep; 2020 Sep; 9(3):219-230. PubMed ID: 32594318
[TBL] [Abstract][Full Text] [Related]
15. Omics technologies in personalized combination therapy for cardiovascular diseases: challenges and opportunities.
Banerjee S; Prabhu Basrur N; Rai PS
Per Med; 2021 Sep; 18(6):595-611. PubMed ID: 34689602
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry based proteomics and metabolomics in personalized oncology.
Kowalczyk T; Ciborowski M; Kisluk J; Kretowski A; Barbas C
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165690. PubMed ID: 31962175
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
Psarros C; Lee R; Margaritis M; Antoniades C
Maturitas; 2012 Sep; 73(1):52-60. PubMed ID: 22261366
[TBL] [Abstract][Full Text] [Related]
18. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
Pecak M; Korošec P; Kunej T
OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
[TBL] [Abstract][Full Text] [Related]
19. Insights into atherosclerosis using nanotechnology.
Jayagopal A; Linton MF; Fazio S; Haselton FR
Curr Atheroscler Rep; 2010 May; 12(3):209-15. PubMed ID: 20425261
[TBL] [Abstract][Full Text] [Related]
20. Nutrigenetics and nutrigenomics: ready for clinical use or still a way to go?
Koromina M; Konstantinidou V; Georgaka M; Innocenti F; Patrinos GP
Per Med; 2020 May; 17(3):171-173. PubMed ID: 32329405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
